Fibroscan联合人体测量学指标诊断非酒精性脂肪性肝病效能分析

doi:10.3969/j.issn.1672-5069.2017.06.029

Abstract

Wang Qian,Guo Ping. Application of fibroscan and anthropometric parameters in diagnosis of patients with nonalcoholic fatty liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 754-755.

[1] Wei J. Non-alcoholic fatty liver disease:Epidemiology,clinical course,investigation,and treatment. Deutsches Rzteblatt Int,2014,111（26）:447-452.
[2] 顾伟根,冯静亚. 超重和肥胖人群非酒精性脂肪性肝病的流行现状及相关危险因素分析. 甘肃医药,2015,34（2）:109-112.
[3] 周龙,张茜,余会元. 影像学检查诊断非酒精性脂肪性肝病研究进展. 实用肝脏病杂志,2015,18（4）：437-440.
[4] Pathik P,Ravindra S,Ajay C,et al.Fibroscan versus simple noninvasive screening tools in predicting fibrosis in high-risk nonalcoholic fatty liver disease patients from Western India. Ann Gastroenterol,2015,28（2）:281-286.
[5] 信丰智,范建高. 欧洲非酒精性脂肪性肝病诊疗指南简介. 实用肝脏病杂志,2016,19（4）：ⅤⅡ-ⅤⅢ.
[6] Than NN,Newsome PN. Non-alcoholic fatty liver disease:when to intervene and with what. Clin Med,2015,15（2）:186-190.
[7] Festi D,Schiumerini R,Marzi L,et al. Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. Aliment Pharmacol Ther,2013,37（4）:392-400.
[8] 付晓丽,刘莉,平智广,等. 人体测量学指标与多重代谢异常的非线性典型相关分析. 卫生研究,2013,42（5）:730-735.
[9] 胡滨,梁惠文,赵辉,等. 肥胖三种诊断指标与非酒精性脂肪性肝病的关系. 中华临床医师杂志（电子版）,2013,7（7）:2888-2891.
[10] 郑瑞丹,陈建能,范建高,等. 非酒精性脂肪性肝病患者尿酸水平与人体测量学指标的研究.中国肝脏病杂志（电子版）,2014,6（3）：6-9.
[11] Yoo HJ,Park MS,Lee CH,et al. Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians．Liver Int,2010,30（8）：1189-1196.
[12] 刘欣,吴绍燕,张明军,等. 人体测量学指标在非酒精性脂肪性肝病筛查中的应用. 重庆医学,2014,43（32）:4343-4345.
[13] 卢加发,刘文斌,潘勤,等. 健康体检成人FibroScan检测肝脏硬度值与受控衰减参数的相关分析,实用肝脏病杂志,2014,17（5）:484-488.
[14] 孙婉璐,范建高. 受控衰减参数在脂肪肝诊断中的应用. 肝脏,2015,20（2）:160-163.
[15] 李力,姜子廷,蔡敏,等. 瞬时弹性成像系统在非酒精性脂肪性肝病中的诊断价值及其与中医分型的关系.中西医结合肝病杂志,2016,26（2）:79-80.
[16] 李红,王国栋,陈斌,等. 瞬时弹性成像技术实施受控衰减参数定量评价非酒精性脂肪性肝病的临床研究.中西医结合肝病杂志,2015,25（6）:361-363.

Application of fibroscan and anthropometric parameters in diagnosis of patients with nonalcoholic fatty liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[2]	Zhong Yan, Su Shuting, Mi Yuqiang.. Treatment of patients with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 145-148.
[3]	Dong Xuelian, Zhang Wenjun.. Application of controlled attenuation parameter in screening individuals with risk of metabolic syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 868-871.
[4]	Huang Faguang, Li Xiaocheng, Gong Jianping, et al.. Research on insulin resistance related protein molecules in human liver tissues by comprehensive gene expression profiling analysis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 872-876.
[5]	Pu Yonglan, Chen Yuanwen, Fan Jiangao.. Gluten intestinal disease and nonalcoholic fatty liver: One case report [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 981-982.
[6]	Zeng Minde. Mechanisms of lipotoxicity in pathogenesis of nonalcoholic fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 153-156.
[7]	Li Yan，Wang Caihua.. Hot spots in dietary therapy in patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 529-531.
[8]	Pang Xiaoning，Liu Yanjun.. A comparative study of liraglutide,sitagliptin and pioglitazone in the treatment of patients with nonalcoholic fatty liver diseases and type 2 diabetes mellitus [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 604-605.
[9]	Guan Jun, Xu Ye. Risk factors of nonalcoholic fatty liver diseases in adolescents [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 347-349.
[10]	Sun Changgui， Zeng Jing，Sun Wanlu，et al.. Changes of estimated glomerular filtration rates in healthy check-up adults with nonalcoholic fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 165-170.
[11]	Cui Xiaomeng, Liu Xin, Shi Haitao, et al.. Effects of diammonium glycyrrhizinate lipid ligand on AMPKα signaling pathways in rats with nonalcoholic fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 55-59.
[12]	Shen Feifei, Lu Lungen.. Noninvasive assessment of liver fibrosis by transient elastography in patients with chronic liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 620-623.
[13]	Xu Xiaoluan, Meng Fankun, Sun Lijuan. Application of transient elastography and portal hemodynamics indexes in diagnosis of hepatic fibrosis in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 432-435.
[14]	Zeng Jing, Chen Guangyu, Pan Qin, e t al. Detection of controlled attenuation parameter of spleen in diagnosis of fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 445-450.
[15]	Zeng Mingde. Achievements and perspectives in nonalcoholic fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 129-131.